With numerous reported challenges to reporting MICs for vancomycin, clinical laboratories are attempting to identify accurate methods for MIC testing. However, the issues of poor reproducibility, accuracy, and clinical utility remain a challenge. In this Point-Counterpoint, Dr. Sara Revolinski discusses the pros of reporting MICs for vancomycin, while Dr. Christopher Doern argues for the use of caution.

中文翻译：

---

点对点：临床微生物学实验室是否应该报告万古霉素 MIC？

由于报告万古霉素的 MIC 存在许多挑战，临床实验室正试图确定 MIC 测试的准确方法。然而，重现性、准确性和临床实用性差的问题仍然是一个挑战。在这个 Point-Counterpoint 中，Sara Revolinski 博士讨论了报告万古霉素 MIC 的优点，而 Christopher Doern 博士则主张谨慎使用。